Vaccines for Children
Closed Solicitation Posted
This opportunity was awarded. See its 5 award notices in the notice history.
- Solicitation number
- 72514
- Agency
- National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention requires the award of indefinite delivery, indefinite quantity contracts to purchase a minimum of 100 doses up to maximum quantities ranging from 100,000 to 13 million doses of 21 pediatric vaccines for its Vaccines for Children program. Offerors must be licensed by the FDA to manufacture the vaccines and agree to provide them with 12-month minimum shelf lives at fixed prices for delivery within 15 days of order to CDC depots. Proposals are due by February 3, 2023 and contracts will have a period of performance from April 1, 2023 through March 31, 2024. Evaluation criteria will include past performance, EDI capabilities, and status as an authorized distributor of record.
No set-aside designation was used. NAICS code 325412 and PSC code 6515 are applicable. Vaccines shall be shipped F.O.B. destination to the 50 states and U.S. territories. Any questions must be submitted in writing by January 27, 2023.
Notice text
2 versions
Update #2 · Latest ·
The Centers for Disease Control and Prevention (CDC), National Center for
Immunization and Respiratory Diseases (NCIRD) requires the award of one
or more indefinite quantity, indefinite delivery contracts for the purchase
of the following pediatric vaccines and estimated quantities manufactured
under a current establishment and product license issued by the U.S. Food
and Drug Administration:
ITEM SUPPLIES / SERVICES QTY / UNIT
Dengue vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 50K Doses
Minimum: 100 Doses
DTaP vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 6.5M Doses
Minimum: 100 Doses
DTaP/Hep B/IPV vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.75 per dose
Maximum: 5.38M Doses
Minimum: 100 Doses
DTaP-IPV vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.00 per dose
Maximum: 3.5M Doses
Minimum: 100 Doses
DTaP-IP-HIB vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.75 per dose
Maximum: 7.5M Doses
Minimum. 100 Doses
DTaP-IPV-HIB-HEPB vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $4.50 per dose
Maximum: 1.75M Doses
Minimum. 100 Doses
E-IPV vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 4M Doses
Minimum: 100 Doses
Hepatitis A (pediatric) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 8.5M Doses
Minimum: 100 Doses
Hepatitis A&B (Age 18 only) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 100K Doses
Minimum: 100 Doses
Hepatitis B (pediatric/adol.) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 7.7M Doses
Minimum: 100 Doses
Hib vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 8M Doses
Minimum: 100 Doses
Human Papillomavirus vaccine, Recombinant
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 9M Doses
Minimum: 100 Doses
Measles, Mumps & Rubella (MMR) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 8M Doses
Minimum: 100 Doses
Meningococcal Conjugate (MCV4) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 6.5M Doses
Minimum: 100 Doses
Pneumococcal Conjugate vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 13M Doses
Minimum: 100 Doses
Pneumococcal (23 Valent) Polysaccharide vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 350K Doses
Minimum: 100 Doses
Rotavirus vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 7M Doses
Minimum: 100 Doses
Tetanus and Diphtheria (Td) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 750K Doses
Minimum: 100 Doses
Tdap vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 5.5M Doses
Minimum: 100 Doses
Varicella vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 10M Doses
Minimum: 10 Doses
Measles, Mumps & Rubella and Varicella (MMR-V) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.00 per dose
Maximum: 3.4M Doses
Minimum: 10 Doses
Serogroup B Meningococcal vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 2.5M Doses
Minimum: 100 Doses
The vaccines awarded under these contracts will be purchased for and by
NCIRD's Immunization Awardees to support pediatric immunization
programs as provided under Section 317(j) of the Public Health Service Act
and Vaccine for Children (VFC) program, established pursuant to Section
13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93). This
acquisition will be conducted in accordance with FAR Part 12, Acquisition
of Commercial Items. Vaccines shall be shipped F.O.B. Destination to the 50
states and U.S. Territories.
The period of performance shall be 4/1/2023 – 3/31/2024.
Any questions regarding this notice shall be submitted in writing to
Christina McMichael at wpn6@cdc.gov. Telephone inquiries will not be
honored.
Update on 2.1.2023:
The proposal due date is extended to Friday, February 3, 2023 at 12:00 PM EST. Note that the question and answer period ended previoulsy and no questions submitted after the due date will receive a response.
Update #1 ·
The Centers for Disease Control and Prevention (CDC), National Center for
Immunization and Respiratory Diseases (NCIRD) requires the award of one
or more indefinite quantity, indefinite delivery contracts for the purchase
of the following pediatric vaccines and estimated quantities manufactured
under a current establishment and product license issued by the U.S. Food
and Drug Administration:
ITEM SUPPLIES / SERVICES QTY / UNIT
Dengue vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 50K Doses
Minimum: 100 Doses
DTaP vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 6.5M Doses
Minimum: 100 Doses
DTaP/Hep B/IPV vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.75 per dose
Maximum: 5.38M Doses
Minimum: 100 Doses
DTaP-IPV vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.00 per dose
Maximum: 3.5M Doses
Minimum: 100 Doses
DTaP-IP-HIB vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.75 per dose
Maximum: 7.5M Doses
Minimum. 100 Doses
DTaP-IPV-HIB-HEPB vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $4.50 per dose
Maximum: 1.75M Doses
Minimum. 100 Doses
E-IPV vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 4M Doses
Minimum: 100 Doses
Hepatitis A (pediatric) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 8.5M Doses
Minimum: 100 Doses
Hepatitis A&B (Age 18 only) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 100K Doses
Minimum: 100 Doses
Hepatitis B (pediatric/adol.) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 7.7M Doses
Minimum: 100 Doses
Hib vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 8M Doses
Minimum: 100 Doses
Human Papillomavirus vaccine, Recombinant
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 9M Doses
Minimum: 100 Doses
Measles, Mumps & Rubella (MMR) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 8M Doses
Minimum: 100 Doses
Meningococcal Conjugate (MCV4) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 6.5M Doses
Minimum: 100 Doses
Pneumococcal Conjugate vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 13M Doses
Minimum: 100 Doses
Pneumococcal (23 Valent) Polysaccharide vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 350K Doses
Minimum: 100 Doses
Rotavirus vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 7M Doses
Minimum: 100 Doses
Tetanus and Diphtheria (Td) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 750K Doses
Minimum: 100 Doses
Tdap vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 5.5M Doses
Minimum: 100 Doses
Varicella vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 10M Doses
Minimum: 10 Doses
Measles, Mumps & Rubella and Varicella (MMR-V) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $3.00 per dose
Maximum: 3.4M Doses
Minimum: 10 Doses
Serogroup B Meningococcal vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 2.5M Doses
Minimum: 100 Doses
The vaccines awarded under these contracts will be purchased for and by
NCIRD's Immunization Awardees to support pediatric immunization
programs as provided under Section 317(j) of the Public Health Service Act
and Vaccine for Children (VFC) program, established pursuant to Section
13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93). This
acquisition will be conducted in accordance with FAR Part 12, Acquisition
of Commercial Items. Vaccines shall be shipped F.O.B. Destination to the 50
states and U.S. Territories.
The period of performance shall be 4/1/2023 – 3/31/2024.
Any questions regarding this notice shall be submitted in writing to
Christina McMichael at wpn6@cdc.gov. Telephone inquiries will not be
honored.
Attachments
| File | Type | Posted |
|---|---|---|
| A19 - Solicitation 1.18.22.doc | DOC document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Notice of Intent to Sole Source - Sanofi Pasteur Inc. | Pre-Solicitation | |
| Notice of Intent to Sole Source - Pfizer, Inc. | Pre-Solicitation | |
| Vaccines for Children | Award Notice | |
| Vaccines for Children | Award Notice | |
| Vaccines for Children | Award Notice | |
| Vaccines for Children | Solicitation |
And 2 more award notices.
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity